Walleye Capital LLC Axsome Therapeutics, Inc. Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $39,465 - $47,920	-500 Reduced 29.41%	1,200 $107,000
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $400,892 - $491,050	-6,100 Reduced 78.21%	1,700 $136,000
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $457,974 - $644,424	6,600 Added 550.0%	7,800 $622,000
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $229,680 - $334,440	-4,000 Reduced 76.92%	1,200 $95,000
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $27,700 - $32,884	400 Added 8.33%	5,200 $363,000
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $280,368 - $433,680	4,800 New	4,800 $344,000
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $323,514 - $645,732	8,100 Added 231.43%	11,600 $894,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $126,210 - $244,474	3,500 New	3,500 $156,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.